Navigation Links
New Options Available for the 13 Million Men Who Suffer from Testosterone Deficiency
Date:9/1/2009

Although female hormone replacement has been the center of attention, male hormone levels are just as important to health and wellness. More men are getting tested and more treatment options are becoming available.

Dallas, TX (PRWEB) September 1, 2009 -- While all the news over the last decade seems to revolve around female hormones, more physicians are seeing the need to test and treat their male patients for testosterone deficiency. A new study suggests that as many as 13 million men may suffer from a deficiency of testosterone. Some physicians feel that the findings are consistent with more men asking for help. "The stigma associated with asking for help is gone. Some of this may be due to the increased drug advertisements targeted for men," states Dr. Anderson, MD of Executive Medicine of Texas

Testosterone deficiency is a serious problem and not only is associated with sexual dysfunction, but can also cause loss of muscle mass, weight gain, higher cholesterol levels, cardiovascular disease and other disorders. Patients with low testosterone levels may feel sluggish or depressed. Personal relationships can suffer too, due to the patient's lack of enthusiasm or interest.

Testosterone creams and injections have been in the mainstream of health care treatments and available to patients in the past. The good news is that the FDA announced the approval of the first long-acting Testosterone replacement treatment. Testopel® is manufactured by Slate Pharmaceuticals and is administered by a growing number of physicians. It consists of small pellets that are inserted under the skin just below the beltline during an in-office procedure. The procedure lasts only a few minutes and is done without sedation or stitches.

"Our patients are thrilled that we can do this procedure and they don't have to think about it again for up to six months." Walter Gaman, MD of Executive Medicine of Texas continues, "Since we are always looking for proven treatments to better help our patients, Testopel® is a welcome addition."

Dr. Gaman was one of the first physicians to offer this treatment within his practice, after it became FDA approved this year. The procedure is quick and easy, but does take a skilled physician to administer. Physicians administering the pellets should be properly instructed on administration and appropriate prescribing.

Executive Medicine of Texas is a leading provider in men's health and wellness. They treat executives and high profile individuals from around the globe and now offer Testopel® as an in-office procedure. The cost per insertion is $1200, which includes a three month testosterone blood level. Insertions can last up to six months, but blood tests can check to ensure that levels are remaining adequate, whereas small number of patients may metabolize the hormone faster requiring insertions to be repeated before the six month mark.

To schedule testing for testosterone deficiency or if you have documented deficiency and wish to schedule a Testopel® insertion, call (817) 552-4300 or (800) 910-EXEC. To learn more about Executive Medicine of Texas, visit http://www.emtexas.com. To learn more about Testopel®, visit http://www.testopel.com.

###

Read the full story at http://www.prweb.com/releases/2009/09/prweb2815284.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Georgia Reproductive Specialists Free Infertility Seminar: Fertility Options 101
2. ValueOptions(R) Awards Coordination of Benefits and Overpayment Services Contract to HMS
3. Blue Cross and Blue Shield Association Introduces Interactive Navigation Solution That Helps Individuals and Families Find Healthcare Coverage Options
4. Commercial Real Estate Group of Tucson Unveils Online Tool that Quickly Informs Commercial Real Estate Tenants of Lease Options
5. FREE INFERTILITY SEMINAR: Fertility Options 101
6. ValueOptions Wins Maryland Mental Health Contract
7. Pennsylvanians With Disabilities Call for an End to Institution-Only Options
8. TCS Healthcare Technologies to Offer Remote Hosting Options for Acuity Advanced Care(TM)
9. Health Insurance Options for Domestic Partnerships
10. 'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer
11. Hybrid Concierge Medical Practice Provides More Value, Options to Growing Number of Physicians Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Options Available for the 13 Million Men Who Suffer from Testosterone Deficiency
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... celebrate the profession and recognize the positive impact veterinarians have on animal health ... and the World Organization for Animal Health (OIE) choose a theme each year ...
(Date:4/28/2017)... NC (PRWEB) , ... April 28, 2017 , ... ... announce its new partnership with the Home Care Association of America (HCAOA). This ... and Private Duty Accreditation services, as well as discounts on Accreditation University (AU) ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Beginning in ... of their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure ... changing the formula in the following ways:, , Removal of ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... distribution of the GlycoMark test throughout the Northeast U.S. , GlycoMark is ... with diabetes. The GlycoMark test provides a clinically proven one- to two-week measure ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: